Page results
-
This is a unique service screening women at risk of ovarian cancer due to a strong family history.
-
We run two separate Urogynaecology services at UCH: the Urogynaecology and Pelvic Floor Unit and the Female Pelvic Medicine and Reconstructive Surgery Unit.
-
At your first visit to UCLH your midwife will discuss birth place options with you and recommend a place of birth.
-
This booklet explains what you can expect during recovery from your autologous stem cell transplant.
-
The TB network for north central London aims to reduce the capital’s high number of new cases and making it easier for patients to receive treatment.
-
This patient information offers advice for patients suffering from long COVID regarding a healthy diet and nutrition.
-
This page is for women who use the UCLH maternity Hypertension service during pregnancy and the postnatal period.
-
We provide a comprehensive service from early diagnosis to advanced treatments for severe COPD. We have a strong multidisciplinary team (MDT) including doctors, specialist nurses, physiotherapists, physiologists and psychologists, which enables us to provide holistic, personalised care to each of our patients.
-
Patient information which describes what miscarriages are, and why they occur, explains what treatment options are available, describes expectant management in detail, explains what can be expected during your recovery from a miscarriage and discusses future pregnancies.
-
We offer an expert service for complex pulmonary embolic disease (PED) and follow up for all cases diagnosed with this condition at UCLH.
File results
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis